Epidemiology of Renal Cell Carcinoma

Slides:

Advertisements

Similar presentations

Volume 60, Issue 4, Pages (October 2011)

Advertisements

Volume 44, Pages S43-S52 (September 2016)

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Testosterone Therapy in Men With Prostate Cancer

Volume 66, Issue 6, Pages (December 2014)

Global Trends in Testicular Cancer Incidence and Mortality

Volume 61, Issue 6, Pages (June 2012)

The Role of Tobacco Smoke in Bladder and Kidney Carcinogenesis: A Comparison of Exposures and Meta-analysis of Incidence and Mortality Risks Marcus G.

Epidemiology and Risk Factors of Urothelial Bladder Cancer

Volume 51, Issue 1, Pages (January 2007)

Volume 73, Issue 3, Pages (March 2018)

Volume 52, Issue 3, Pages (September 2007)

Volume 69, Issue 1, Pages (January 2016)

Volume 69, Issue 1, Pages 4-6 (January 2016)

Lymph Node Dissection in Renal Cell Carcinoma

Volume 54, Issue 4, Pages (October 2008)

Let the Games Begin (with EAU Approval)

Volume 68, Issue 1, Pages (July 2015)

Prostate Cancer Epidemic in Sight?

Volume 56, Issue 3, Pages (September 2009)

Volume 66, Issue 3, Pages (September 2014)

Volume 63, Issue 1, Pages (January 2013)

Bladder Cancer: A Major Public Health Issue

The Global Risk of Bladder Cancer: Let's Just Do Something About It!

The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.

Volume 67, Issue 2, Pages (February 2015)

Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey John B. McKinlay, Carol L. Link European.

Volume 54, Issue 4, Pages (October 2008)

Volume 52, Issue 5, Pages (November 2007)

Volume 68, Issue 1, Pages 5-7 (July 2015)

Volume 70, Issue 3, Pages (September 2016)

Prostate Cancer Detection: A View of the Future

Volume 57, Issue 4, Pages (April 2010)

Low-risk Prostate Cancer: Identification, Management, and Outcomes

Volume 64, Issue 4, Pages (October 2013)

Volume 60, Issue 5, Pages (November 2011)

Shaheen Alanee, Kasmintan Schrader, Kenneth Offit European Urology

Volume 72, Issue 3, Pages (September 2017)

International Society of Urological Pathology Grading and Other Prognostic Factors for Renal Neoplasia Brett Delahunt, John R. Srigley, Lars Egevad,

Prostate Cancer Epidemic in Sight?

Volume 50, Issue 3, Pages (September 2006)

Volume 64, Issue 4, Pages (October 2013)

Global Burden of Urologic Cancers, 1990–2013

The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer

Volume 61, Issue 6, Pages (June 2012)

Volume 66, Issue 6, Pages (December 2014)

Volume 66, Issue 6, Pages (December 2014)

Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia

Volume 71, Issue 1, Pages (January 2017)

Volume 59, Issue 1, Pages (January 2011)

Volume 60, Issue 6, Pages (December 2011)

Use of the National Health and Nutrition Examination Survey to Calculate the Impact of Obesity and Diabetes on Cost and Prevalence of Urolithiasis in.

Volume 56, Issue 5, Pages (November 2009)

Volume 50, Issue 5, Pages (November 2006)

Volume 58, Issue 3, Pages (September 2010)

CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System

Volume 55, Issue 3, Pages (March 2009)

Testicular Cancer Variations in Time and Space in Europe

Volume 74, Issue 4, Pages (October 2018)

Volume 54, Issue 4, Pages (October 2008)

Volume 59, Issue 4, Pages (April 2011)

Sergio Bracarda European Urology Supplements

European Urology is “Your” Journal

Economic Burden of Bladder Cancer Across the European Union

Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson

Clinical Management of Patients Receiving Tyrosine Kinase Inhibitors for Advanced Renal Cell Carcinoma Jan Roigas European Urology Supplements Volume.

Joaquim Bellmunt European Urology Supplements

Jan Roigas European Urology Supplements

Does PSA Testing Influence the Natural History of Prostate Cancer?

Volume 51, Issue 5, Pages (May 2007)

Presentation transcript:

Epidemiology of Renal Cell Carcinoma Umberto Capitanio, Karim Bensalah, Axel Bex, Stephen A. Boorjian, Freddie Bray, Jonathan Coleman, John L. Gore, Maxine Sun, Christopher Wood, Paul Russo European Urology Volume 75, Issue 1, Pages 74-84 (January 2019) DOI: 10.1016/j.eururo.2018.08.036 Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 1 World incidence ASRs for both sexes. Numbers are expressed per 100000 people. Reproduced with permission from the International Agency for Research on Cancer [3]. ASR=age-standardised rate. European Urology 2019 75, 74-84DOI: (10.1016/j.eururo.2018.08.036) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 2 World prevalence proportions for both sexes. Numbers are expressed per 100000 people. Reproduced with permission from the International Agency for Research on Cancer [3]. European Urology 2019 75, 74-84DOI: (10.1016/j.eururo.2018.08.036) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 3 World mortality ASRs for both sexes. Numbers are expressed per 100000 people. Reproduced with permission from the International Agency for Research on Cancer [3]. ASR=age-standardised rate. European Urology 2019 75, 74-84DOI: (10.1016/j.eururo.2018.08.036) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 4 Cumulative risk of incidence and mortality of kidney cancer stratified for gender and world regions. Numbers are expressed per 100000 people. Reproduced with permission from the International Agency for Research on Cancer [3]. European Urology 2019 75, 74-84DOI: (10.1016/j.eururo.2018.08.036) Copyright © 2018 European Association of Urology Terms and Conditions